Concord Drugs share news and announcements
BSE: 538965Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹69.00.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹90 Cr3,001st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 10 Aug 2026
- 43.7
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 10 Aug 2026
- 5.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 10 Aug 2026
- 7.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 May 2026
- 0.28
- Volume, BSEVolume. Shares traded on the last trading day.
- 1,703
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Concord Drugs quarterly results
The board met on 10 Aug 2026 to consider quarterly results
Notice filed 3 Aug 2026
Concord Drugs annual reports, presentations and earnings calls
The company's own documents, latest first.Concord Drugs financials, year by year
Annual reports14
- Annual report, year to Mar 2026 (opens in a new tab)7 Sep 2026
- Annual report, year to Mar 2025 (opens in a new tab)9 Sep 2025
- Annual report, year to Mar 2024 (opens in a new tab)6 Sep 2024
- Annual report, year to Mar 2023 (opens in a new tab)8 Sep 2023
- Annual report, year to Mar 2022 (opens in a new tab)8 Sep 2022
9 earlier reports
- Annual report, year to Mar 2021 (opens in a new tab)8 Sep 2021
- Annual report, year to Mar 2020 (opens in a new tab)7 Dec 2020
- Annual report, year to Mar 2019 (opens in a new tab)6 Sep 2019
- Annual report, year to Mar 2018 (opens in a new tab)17 Oct 2018
- Annual report, year to Mar 2017 (opens in a new tab)29 Sep 2017
- Annual report, year to Mar 2016 (opens in a new tab)15 Oct 2016
- Annual report, year to Mar 2014 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2013 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2012 (opens in a new tab)Filing day not known
Concord Drugs share news and announcements
433 announcements, routine notices left out, newest first. Page 1 of 9.
Oct 2026
Sep 2026
30 Sep · Meeting
7 Sep · Letter To Shareholders
7 Sep · Meeting
Aug 2026
10 Aug · Results
3 Aug · Board meeting
Meeting on 10 Aug 2026: quarterly results
May 2026
18 May · Board meeting
Meeting on 27 May 2026: audited results
Apr 2026
10 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Feb 2026
14 Feb · Announcement under Regulation 30 (LODR)-Retirement
2 Feb · Board meeting
Meeting on 14 Feb 2026: quarterly results
Dec 2025
Nov 2025
24 Nov · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
20 Nov · Announcement under Regulation 30 (LODR)-Allotment
13 Nov · Results
4 Nov · Board meeting
Meeting on 13 Nov 2025: quarterly results
Oct 2025
1 Oct · Meeting
Sep 2025
30 Sep · Meeting
8 Sep · Letter To Shareholders
8 Sep · Annual Report
8 Sep · Meeting
8 Sep · Meeting
8 Sep · Board meeting
Aug 2025
8 Aug · Results
1 Aug · Board meeting
Meeting on 8 Aug 2025: quarterly results1 Aug · Meeting
Jul 2025
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 30 Dec 2025Order receivedup 3.44%+3.5 pts vs Nifty 500market median +1.1% · five sessions +1.7% (+0.1 pts vs Nifty 500) · volume 9.7× usual · The announcement (opens in a new tab)
- 9 Sep 2025Board or managers changedup 2.00%+1.7 pts vs Nifty 500market median 0.0% · five sessions +4.5% (+3.1 pts vs Nifty 500) · volume 1.1× usual · The announcement (opens in a new tab)
- 10 Apr 2023Board or managers changedup 0.24%0.0 pts vs Nifty 500market median 0.0% · five sessions +5.9% (+4.9 pts vs Nifty 500) · volume 2.3× usual · The announcement (opens in a new tab)
- 11 Nov 2022Board or managers changedup 0.15%−1.2 pts vs Nifty 500market median 0.0% · five sessions −5.0% (−6.0 pts vs Nifty 500) · volume 0.7× usual · The announcement (opens in a new tab)
- 2 Jun 2022Board or managers changeddown 3.45%−4.1 pts vs Nifty 500market median 0.0% · five sessions −5.6% (−4.2 pts vs Nifty 500) · volume 1.3× usual · The announcement (opens in a new tab)
- 9 May 2022Board or managers changedup 1.25%+2.3 pts vs Nifty 500market median 0.0% · five sessions 0.0% (+4.8 pts vs Nifty 500) · volume 0.2× usual · The announcement (opens in a new tab)
- 18 Apr 2019Board or managers changedup 4.58%+5.0 pts vs Nifty 500market median 0.0% · five sessions +5.0% (+6.6 pts vs Nifty 500) · volume 1.5× usual · The announcement (opens in a new tab)
- 23 May 2018Board or managers changedup 1.14%+2.0 pts vs Nifty 500market median 0.0% · five sessions −3.2% (−4.6 pts vs Nifty 500) · volume 0.5× usual · The announcement (opens in a new tab)
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Materials used | Year to date to Sep 2025 | Standalone | 18.49 | 18.36 | −0.7% | 13 Nov 2025 (opens in a new tab) | 14 Feb 2026 (opens in a new tab) |
| Total expenses | Year to date to Sep 2025 | Standalone | 23.17 | 23.04 | −0.6% | 13 Nov 2025 (opens in a new tab) | 14 Feb 2026 (opens in a new tab) |
| Profit before tax | Year to date to Sep 2025 | Standalone | 0.29 | 0.42 | +47.2% | 13 Nov 2025 (opens in a new tab) | 14 Feb 2026 (opens in a new tab) |
| Tax | Year to date to Sep 2025 | Standalone | 0.08 | 0.12 | +43.5% | 13 Nov 2025 (opens in a new tab) | 14 Feb 2026 (opens in a new tab) |
| Net profit | Year to date to Sep 2025 | Standalone | 0.21 | 0.31 | +48.6% | 13 Nov 2025 (opens in a new tab) | 14 Feb 2026 (opens in a new tab) |
| Profit before one-off items and tax | Year to date to Sep 2025 | Standalone | 0.29 | 0.42 | +47.2% | 13 Nov 2025 (opens in a new tab) | 14 Feb 2026 (opens in a new tab) |
| Current tax | Year to date to Sep 2025 | Standalone | 0.09 | 0.13 | +37.2% | 13 Nov 2025 (opens in a new tab) | 14 Feb 2026 (opens in a new tab) |
| Net profit from continuing businesses | Year to date to Sep 2025 | Standalone | 0.21 | 0.31 | +48.6% | 13 Nov 2025 (opens in a new tab) | 14 Feb 2026 (opens in a new tab) |
| Total comprehensive income | Year to date to Sep 2025 | Standalone | 0.21 | 0.31 | +48.6% | 13 Nov 2025 (opens in a new tab) | 14 Feb 2026 (opens in a new tab) |